title: The changing landscape of phase I trials in oncology.
authors.affiliation: From the Developmental Therapeutics Program, Division of Medical Oncology, Department of Medicine, University of Colorado, Aurora, CO.
authors.forename: Kit Man
authors.initials: KM
authors.lastname: Wong
authors.affiliation: From the Developmental Therapeutics Program, Division of Medical Oncology, Department of Medicine, University of Colorado, Aurora, CO.
authors.forename: Anna
authors.initials: A
authors.lastname: Capasso
authors.affiliation: From the Developmental Therapeutics Program, Division of Medical Oncology, Department of Medicine, University of Colorado, Aurora, CO.
authors.forename: S Gail
authors.initials: SG
authors.lastname: Eckhardt
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008495:Medical Oncology / Q000379:methods / Q000639:trends*; D017063:Outcome Assessment, Health Care / Q000379:methods; D018579:Patient Selection; D012107:Research Design
chemical_list: D000970:Antineoplastic Agents